ASCO publishes a suite of peer-reviewed journals with content focused on

  • clinical oncology research;
  • issues and insights affecting oncology practice;
  • cancer care, research and care delivery issues unique to countries and settings with limited healthcare resources;
  • biomedical informatics methods and processes applied to cancer-related data, information, and images; and
  • the science and practice of precision oncology.

ASCO’s peer-reviewed journals follow a continuous publication schedule. Below is a select list of the newest content from ASCO’s journals. ASCO will update the list on a near-daily basis, and we encourage you to check this page frequently. Email ASCO’s Media Team to request an embargoed journal article or an interview with a study author.

ASCO occasionally highlights select journal articles in an embargoed press release known as a News Digest or in a Featured Article summary. Sign up to receive communications regarding these articles.

Publishing January 21, 2020, 4:00 pm ET: 

Phase IB/II Trial of Lenvatinib Plus Pembrolizumab in Patients With Advanced Renal Cell Carcinoma, Endometrial Cancer, and Other Selected Advanced Solid Tumors (Original Report)
Matthew Taylor, et al.
Request this article

Application of the ASCO Value Framework and ESMO Magnitude of Clinical Benefit Scale to Assess the Value of Abiraterone and Enzalutamide in Advanced Prostate Cancer (Original Contribution)
Srikala Sridhar, et al.
Request this article

Defining Value in Metastatic Prostate Cancer: What Is the Cost of Living Longer and Better? (Editorial)
Cy Stein, et al.
Request this article

Timeliness of Initial Therapy in Multiple Myeloma: Trends and Factors Affecting Patient Care (Original Contribution)
Sikander Ailawadhi, et al.
Request this article

Publishing January 17, 2020, 4:00 pm ET: 

Dose Finding in Physical Activity and Cancer Risk Reduction (Editorial)
Anne McTiernan, et al.
Request this article

Negligible Effects of the Survey Modes for Patient-Reported Outcomes: A Report From the Childhood Cancer Survivor Study (Original Report)
I-Chan Huang, et al.
Request this article

Publishing January 16, 2020, 4:00 pm ET: 

Improving the Time to Activation of New Clinical Trials at a National Cancer Institute-Designated Comprehensive Cancer Center (Original Contribution)
Timothy Brown, et al.
Request this article

Publishing January 15, 2020, 4:00 pm ET: 

Optimum Imaging Strategies for Advanced Prostate Cancer: ASCO Guideline (Special Article)
Bryan Rumble, et al.
Request this article

Publishing January 13, 2020, 4:00 pm ET: 

Pathological Fracture and Prognosis of High-Grade Osteosarcoma of the Extremities: An Analysis of 2,847 Consecutive Cooperative Osteosarcoma Study Group (COSS) Patients (Original Report)
Lisa Kelley, et al.
Request this article

Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update (Special Article)
Shannon McKernin, et al.
Request this article

Cancer and Indigenous Populations: Time to End the Disparity (Editorial)
Eva Segelov, et al.
Request this article

Sharing Wisdom, Sharing Hope: Strategies Used by Native American Cancer Survivors to Restore Quality of Life (Special Article)
Tiana Bastian, et al.
Request this article

Addressing Cancer Health Disparities in the Pacific Peoples of Hawaii, Guam, and the US Associated Pacific Islands Through Pacific-Focused Research Capacity Building (Special Article)
Rachael Leon Guerrero, et al.
Request this article

Creating a Canadian Indigenous Research Network Against Cancer to Address Indigenous Cancer Disparities (Original Report)
Brenda Elias, et al.
Request this article

Optimal Cancer Care for Aboriginal and Torres Strait Islander People: A Shared Approach to System Level Change (Original Report)
Jennifer Chynoweth, et al.
Request this article

Publishing January 10, 2020, 4:00 pm ET: 

Prospective Feasibility Trial of a Novel Strategy of Facilitated Cascade Genetic Testing Using Telephone Counseling (Original Report)
Melissa Frey, et al.
Request this article

Cascading After Peridiagnostic Cancer Genetic Testing: An Alternative to Population-Based Screening (Original Report)
Kenneth Offit, et al.
Request this article

Individualized Asparaginase Dosing in Childhood Acute Lymphoblastic Leukemia (Original Report)
Robin Kloos, et al.
Request this article

Access to WHO Essential Medicines for Childhood Cancer Care in Trinidad and Tobago: A Health System Analysis of Barriers and Enablers (Original Report)
Avram Denburg, et al.
Request this article

High-Cost Cancer Treatment Across Borders in Conflict Zones: Experience of Iraqi Patients in Lebanon (Original Report)
Deborah Mukherji, et al.
Request this article

Publishing January 09, 2020, 4:00 pm ET: 

Prognostic Significance of Patient-Reported Outcomes in Cancer (Original Contribution)
Katie Kerrigan, et al.
Request this article

The embargo date and time of a journal article coincide with its online publication date and time. Journalists may conduct embargoed interviews with study authors up to one week prior to the online publication date. ASCO takes embargo violations seriously and violations typically result in the loss of journal media privileges for a period of one year and may affect broader ASCO media privileges as well. Journalists may request embargoed articles. Please direct further questions regarding the embargo policies for ASCO Journals to the Media Team.